BiotechTube
Home/Virtici/Neil Fanger, PhD
NF

Neil Fanger, PhD

President & CEO

Virtici

Therapeutic Areas

PeriodontitisInflammationAutoimmunityOncologyInfectious Disease

Virtici Pipeline

DrugIndicationPhase
VTC-880PeriodontitisPhase 2
R-3750Ulcerative ColitisPhase 1
R-2487Not SpecifiedPhase 1
R-5780CancerPhase 1